share_log

长春高新:关于子公司GS1-144获得美国食品药品监督管理局新药临床试验申请默示许可的公告

Changchun Hi-Tech: Announcement on Subsidiary GS1-144 Obtaining Implied Approval from the US Food and Drug Administration to Apply for Clinical Trials of New Drugs

SZSI ·  Dec 24
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more